Can foods with added soya-protein or fish-oil reduce risk factors for coronary disease? A factorial randomised controlled trial

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 14, Issue 6, 2004, Pages 344-350

  Harrison, R A ^a   Sagara, M ^b   Rajpura, A ^c   Armitage, L ^d   Birt, N ^e   Birt, C A ^f   Yamori, Y ^g,h  

^a Bolton Primary Care Trust   (United Kingdom)

^b RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT   (Japan)

^c Cumbria Lancashire Specialist C   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e Wirral Primary Care Trusts   (United Kingdom)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g WHO Collaborating Ctr Prim P   (Japan)

^h WHO Collaborating Ctr Res Prim P   (Japan)

Author keywords

Coronary heart disease; Functional foods; Omega3; Primary prevention; Soya protein

Indexed keywords

BIOLOGICAL MARKER; FISH OIL; HIGH DENSITY LIPOPROTEIN; ISOFLAVONOID; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; SOYBEAN PROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BREAD; CARDIOVASCULAR RISK; CEREAL; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 16344362850     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(04)80024-3     Document Type: Article

References (31)

1. Murray C, Lopez A (1996) The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injury and Risk Factors in 1990 and Projected to 2020. Mass., Cambridge.
2. Magnus P, Beaglehole R (2001) The real contribution of the major risk factors to the coronary epidemic: time to end the "only-50%" myth: Arch Intern Med 161: 2657-2660
3. Sacks F (2002) The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: Expert group recommendations. Am J Cardiol 90: 139-143
4. Sprecher D, Watkins T, Behar S, Brown W, Rubins H, Schaefer E (2003) Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease. Am J Cardiol 91: 575-580
5. Kromhout D (2001) Diet and cardiovascular diseases. J Nutr Health Aging 5: 144-149
6. Harris WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30: 785-807
7. Geleijnse J, Giltay E, Grobbee D, Donders A, Kok F (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20: 1493-1499
8. Anderson J, Johnstone B, Cook-Newell M (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333: 276-282
9. Jenkins DJ, Kendall CW, Jackson CJ, et al (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76: 365-372
10. Department of Health. Nutritional aspects of cardiovascular disease (1994) Report of the Cardiovascular Review Group Committee on Medical Aspects of Food. 46, 1-186. The Stationery Office, London.
11. Food and Drug Administration (1999) Food labeling: Health claims, soy protein and coronary heart disease. 26; 64(206): 57700-57733. Federal Register
12. Hardy G (2000) Nutraceuticals and functional foods: introduction and meaning. Nutrition 16: 688-689
13. Stone NJ (2001) Lowering low-density cholesterol with diet: the important role of functional foods as adjuncts. Coron Artery Dis 12: 547-552
14. Huggett AC, Schilter B (1996) Research needs for establishing the safety of functional foods. Nutr Rev 54: S143-S148
15. Birt C, Narayan K (1987) Cardiovascular risk factors and health behavior: Some preliminary findings from the Cardiovascular Diseases and Alimentary Comparison study. J Cardiovasc Pharmacol 16: S15-S17
16. White W, Anwar Y (2001) Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit 6: 107-110
17. Cui Y, Blumenthal R, Flaws J, et al (2001) Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161: 1413-1419
18. Uesugi T, Fukui Y, Yamori Y (2002) Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. J Am Coll Nutr 21: 97-102
19. WHO Collaborating Center on Primary Prevention of Cardio-vascular Diseases and Cardiovascular Diseases Unit (1986) Cardio-vascular Disease and Alimentary Comparison (CARDIAC) Study Protocol and Manual of Operations. Shimane/Geneva, WHO Collaborating Center on Primary Prevention of Cardiovascular Diseases and WHO.
20. Piantadosi S (1997) Clinical Trials. A Methodologic Perspective. John Wiley & Sons, Inc., New York.
21. Hollis S, Campbell F (1999) What is meant by intention to treat analysis? Survey of published randomised controlled trials. Br Med J 319: 670-674
22. Sacco RL, Benson RT, Kargman DE, et al (2001) High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. J Am Med Assoc 285: 2729-2735
23. Robins SJ, Collins D, Wittes JT, et al (2001) Relation of gemfibrozil treatment and lipid levels with major coronary events: VAHIT: a randomized controlled trial. J Am Med Assoc 285: 1585-1591
24. Hulka B, Wilcosky T, Griffith J (1990) Biological Markers in Epidemiology. Oxford University Press, Oxford, p. 1-236
25. Jackevicius C, Mamdani M, Tu J (2002) Adherence with statin therapy in elderly patients with and without acute coronary syndromes. J Am Med Assoc 288: 462-467
26. Bloedon L, Jeffcoat A, Lopaczynski W, et al (2002) Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutrit 76: 1126-1137
27. Teede H, Dalais F, Kotsopoulos D, Liang Y, Davis S, McGrath B (2001) Dietary soy has both beneficial and potentially adverse cardiovascular effects: A placebo-controlled study in men and post-meno-pausal women. J Clin Endocrinol Metab 86: 3053-3060
28. Food Standards Agency (2003) COT Working Group Draft Report on Phytoestrogens. Food Standards Agency, www.food.gov.uk/multimedia/webpage/ phytoreportworddocs
29. GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455
30. Burr ML, Ashfield-Watt PAL, Dunstan FDJ, et al (2003) Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57: 193-200
31. Hooper L, Thompson R, Harrison R, et al (2002) Omega-3 fatty acids for the prevention of cardiovascular disease [protocol for a Cochrane review]. The Cochrane Library [1]. Update Software, Oxford